Overheard Speech for Autism Spectrum Disorder

Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Upduring test phase of the experimental session (e.g., within 5 seconds)
Awards & highlights
No Placebo-Only Group

Study Summary

This trial is testing whether children with ASD can learn new words by overhearing conversations.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during test phase of the experimental session (e.g., within 5 seconds)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during test phase of the experimental session (e.g., within 5 seconds) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Object selection

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OverheardExperimental Treatment1 Intervention
Children are present in the room while an experimenter uses the word to be learned in an interaction with another experimenter.
Group II: AddressedActive Control1 Intervention
Children participate in an interaction with an experimenter who uses the word to be learned.

Find a site

Who is running the clinical trial?

New York UniversityLead Sponsor
217 Previous Clinical Trials
313,553 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
1,450 Patients Enrolled for Autism Spectrum Disorder
Emerson CollegeOTHER
3 Previous Clinical Trials
550 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
450 Patients Enrolled for Autism Spectrum Disorder

Media Library

Addressed Speech Clinical Trial Eligibility Overview. Trial Name: NCT05193500 — N/A
Autism Spectrum Disorder Research Study Groups: Addressed, Overheard
Autism Spectrum Disorder Clinical Trial 2023: Addressed Speech Highlights & Side Effects. Trial Name: NCT05193500 — N/A
Addressed Speech 2023 Treatment Timeline for Medical Study. Trial Name: NCT05193500 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been incorporated into this research project?

"Affirmative. According to clinicaltrials.gov, this medical experiment first went public on August 1st 2022 and has been revised most recently as of November 11th 2022. 200 patients will be recruited from two separate sites for the trial's duration."

Answered by AI

Does this clinical trial have an age restriction and if so, what is it?

"This clinical trial stipulates that the lower bound for patient age is 24 months and the upper limit of enrolment eligibility is 71 months."

Answered by AI

Does my profile satisfy the requirements to join this research effort?

"The study requires 200 participants between 24 and 71 months of age who have been diagnosed with Autism Spectrum Disorder. Additional inclusion criteria involves a minimum language and nonverbal cognition age of at least two years old."

Answered by AI
~110 spots leftby Mar 2025